| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Division of Cardiology, University of Utah Health Science Center, Salt Lake City, Utah 84132; and 2 Department of Medicine, University of California, La Jolla, California 92093
Muscle LIM protein (MLP) may serve as a scaffold protein on the actin-based cytoskeleton, and mice deficient in this protein (MLPKO) have been recently reported to develop dilated cardiomyopathy. To determine the causes of depressed contractility in this model, we measured intracellular Ca2+ concentration ([Ca2+]i) transients (fluo 3), cell shortening, L-type Ca2+ channel current (ICa,L), Na/Ca exchanger current (INa/Ca), and sarcoplasmic reticulum (SR) Ca content in left ventricular MLPKO myocytes. ICa,L-voltage relationships, INa/Ca density, and membrane capacitance did not differ between wild-type (WT) and MLPKO myocytes. The peak systolic [Ca2+]i was significantly increased in MLPKO myocytes (603 ± 54 vs. 349 ± 18 nM in WT myocytes). The decline of [Ca2+]i transients was accelerated in MLPKO myocytes, and SR Ca2+ content was increased by 21%, indicating that SR Ca2+-ATPase function is normal or enhanced in MLPKO myocytes. Confocal imaging of actin filaments stained with tetramethylrhodamine isothiocyanate-labeled phalloidin showed disorganization of myofibrils and abnormal alignment of Z bands, and fractional shortening was significantly diminished in MLPKO myocytes compared with that in WT myocytes at comparable peak [Ca2+]i. Thus a reduced [Ca2+]-induced shortening may be involved in the pathogenesis of myocardial dysfunction in this genetic model of heart failure.
cytoskeleton; knockout mouse; dilated cardiomyopathy; Ca2+ transient; excitation-contraction coupling; 2,3-butanedione monoxime
This article has been cited by other articles:
|
|
 |
|
  H. K. Mork, I. Sjaastad, O. M. Sejersted, and W. E. Louch Slowing of cardiomyocyte Ca2+ release and contraction during heart failure progression in postinfarction mice Am J Physiol Heart Circ Physiol, April 1, 2009; 296(4): H1069 - H1079. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Geier, K. Gehmlich, E. Ehler, S. Hassfeld, A. Perrot, K. Hayess, N. Cardim, K. Wenzel, B. Erdmann, F. Krackhardt, et al. Beyond the sarcomere: CSRP3 mutations cause hypertrophic cardiomyopathy Hum. Mol. Genet., September 15, 2008; 17(18): 2753 - 2765. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. O'Rourke The Ins and Outs of Calcium in Heart Failure Circ. Res., June 6, 2008; 102(11): 1301 - 1303. [Full Text] [PDF]
|
|
|
|
|
|
M. L. Valencik, D. Zhang, B. Punske, P. Hu, J. A. McDonald, and S. E. Litwin Integrin Activation in the Heart: A Link Between Electrical and Contractile Dysfunction? Circ. Res., December 8, 2006; 99(12): 1403 - 1410. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Tabibiazar, R. A. Wagner, A. Liao, and T. Quertermous Transcriptional Profiling of the Heart Reveals Chamber-Specific Gene Expression Patterns Circ. Res., December 12, 2003; 93(12): 1193 - 1201. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Watkins Genetic Clues to Disease Pathways in Hypertrophic and Dilated Cardiomyopathies Circulation, March 18, 2003; 107(10): 1344 - 1346. [Full Text] [PDF]
|
|
|
|
|
|
S. R. Houser and K. B. Margulies Is Depressed Myocyte Contractility Centrally Involved in Heart Failure? Circ. Res., March 7, 2003; 92(4): 350 - 358. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
